BioCardia (BCDA) News Today $1.32 -0.08 (-5.71%) Closing price 04:00 PM EasternExtended Trading$1.33 +0.01 (+0.76%) As of 05:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BCDA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period BioCardia Regains Nasdaq Compliance, Secures Continued ListingOctober 2, 2025 | tipranks.comBioCardia Regains Compliance with Nasdaq Listing RequirementsOctober 2, 2025 | globenewswire.comBioCardia (BCDA) Price Target Increased by 158.33% to 15.81September 30, 2025 | msn.comHC Wainwright Comments on BioCardia FY2025 EarningsSeptember 26, 2025 | americanbankingnews.comInsider Buying: BioCardia (NASDAQ:BCDA) CEO Buys 48,000 Shares of StockSeptember 24, 2025 | insidertrades.comBioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart FailureSeptember 22, 2025 | markets.businessinsider.comBioCardia’s Positive Consultation with Japan’s PMDASeptember 22, 2025 | msn.comBullish BioCardia Insider Buying Worth US$1.06m Yet To Pay OffSeptember 20, 2025 | finance.yahoo.comBioCardia stock falls after pricing $6 million public offeringSeptember 19, 2025 | za.investing.comBioCardia Raises $5.1 Million Through Stock SaleSeptember 19, 2025 | tipranks.comBioCardia announces pricing of up to $12M public offeringSeptember 18, 2025 | msn.comBioCardia Announces Pricing of Up To $12 Million Public OfferingSeptember 18, 2025 | globenewswire.comBioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary ...September 18, 2025 | finance.yahoo.comBioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-upSeptember 18, 2025 | globenewswire.comBioCardia files to sell 2.8M shares of common stock, warrantsSeptember 16, 2025 | msn.comBioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025September 4, 2025 | globenewswire.comBioCardia and CART-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3D™ Fusion Imaging for Interventional CardiologyAugust 13, 2025 | finance.yahoo.comBioCardia, Inc. (NASDAQ:BCDA) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | msn.comBioCardia Advances Clinical Trials Amid Financial ChallengesAugust 12, 2025 | msn.comBioCardia, Inc.: BioCardia Reports Second Quarter 2025 Business Highlights and Financial ResultsAugust 12, 2025 | finanznachrichten.deBioCardia Narrows Loss in Fiscal Q2August 12, 2025 | theglobeandmail.comBioCardia outlines regulatory milestones and targets FDA and PMDA submissions for CardiAMP and Helix in Q4 2025August 12, 2025 | msn.comBioCardia, Inc. (BCDA) Q2 2025 Earnings Call TranscriptAugust 11, 2025 | seekingalpha.comBioCardia Reports Second Quarter 2025 Business Highlights and Financial ResultsAugust 11, 2025 | globenewswire.comBioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025August 6, 2025 | globenewswire.comBioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery CatheterAugust 4, 2025 | globenewswire.comHenry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection FractionJuly 16, 2025 | finance.yahoo.comBioCardia, Inc. (NASDAQ:BCDA) CFO David Mcclung Buys 4,819 SharesJuly 3, 2025 | insidertrades.comBioCardia Announces New United States Patent for Helix Biotherapeutic Delivery SystemJune 25, 2025 | finance.yahoo.comBioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025May 21, 2025 | globenewswire.comBioCardia, Inc. (BCDA) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comBioCardia Reports First Quarter 2025 Business Highlights and Financial ResultsMay 14, 2025 | globenewswire.comBioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025May 9, 2025 | globenewswire.comBioCardia Initiates Patient Enrollment For CardiAMP HF II TrialMay 8, 2025 | nasdaq.comInsider Buying Surges in May. Especially These 5 StocksMay 7, 2025 | 247wallst.comBioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal StudyMay 6, 2025 | finance.yahoo.comBioCardia, Inc. (NASDAQ:BCDA) Director Bill Facteau Purchases 13,123 SharesApril 26, 2025 | insidertrades.comBioCardia, Inc.: BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical TrialApril 17, 2025 | finanznachrichten.deAlliance Global Partners Sticks to Its Buy Rating for BioCardia (BCDA)April 17, 2025 | markets.businessinsider.comBioCardia announces independent DSMB recommended CardiALLO-HF trial to continueApril 15, 2025 | markets.businessinsider.comBioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical TrialApril 15, 2025 | tmcnet.comBioCardia initiates enrollment at Emory University for CardiAMP HF II studyApril 11, 2025 | markets.businessinsider.comBioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal StudyApril 11, 2025 | globenewswire.comEarnings call transcript: BioCardia Q4 2024 sees reduced expenses, stock downApril 2, 2025 | uk.investing.comBioCardia’s CardiAMP-HF trial primary endpoint did not reach significanceApril 1, 2025 | markets.businessinsider.comBioCardia, Inc. (BCDA) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comBioCardia's Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time TodayMarch 31, 2025 | globenewswire.comBioCardia Full Year 2024 Earnings: EPS Beats Expectations, Revenues LagMarch 28, 2025 | uk.finance.yahoo.comBioCardia Reports 2024 Business Highlights and Financial ResultsMarch 26, 2025 | globenewswire.comBioCardia, Inc. to Report 2024 Financial Results and Host Conference Call Following CardiAMP-HF Trial PresentationMarch 23, 2025 | nasdaq.com Get BioCardia News Delivered to You Automatically Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BCDA Media Mentions By Week BCDA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCDA News Sentiment▼0.680.55▲Average Medical News Sentiment BCDA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCDA Articles This Week▼32▲BCDA Articles Average Week Get the Latest News and Ratings for BCDA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BioCardia and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AKTX News PYRGF News IMA News CVKD News ALVR News DARE News KLTO News RNTX News KZR News PASG News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCDA) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
